Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018)
Sanara MedTech (SMTI) posted Current Deferred Revenue of $10474.0 for Q4 2018, down 13.73% on a QoQ basis from $12141.0 in Q3 2018, and down 24.76% year-over-year from $13920.0 in Q4 2017.
Sanara MedTech (SMTI) Current Deferred Revenue (2017 - 2018) Analysis & Trends
Sanara MedTech's Current Deferred Revenue history runs 2 years deep, the most recent figure standing at $10474.0 for Q4 2018.
- Quarterly Current Deferred Revenue fell 24.76% year-over-year to $10474.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $10474.0 (down 24.76% YoY) and the FY2018 annual result came in at $10474.0, down 24.76% from the prior year.
- Current Deferred Revenue was $10474.0 for Q4 2018 at Sanara MedTech, down from $12141.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $13920.0 in Q4 2017 and bottomed at $10474.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Sanara MedTech | 233.71 Mn | 220.11 Mn | 25.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 10,474.00 |
| Sep 30, 2018 | 12,141.00 |
| Jun 30, 2018 | 12,913.00 |
| Mar 31, 2018 | 13,703.00 |
| Dec 31, 2017 | 13,920.00 |